Success Metrics

Clinical Success Rate

83.3%

Based on 10 completed trials

Completion Rate

83%(10/12)

Active Trials

1(6%)

Results Posted

70%(7 trials)

Terminated

2(13%)

Phase Distribution

Ph phase_3

13%

Ph phase_4

31%

Ph phase_1

Ph not_applicable

38%

Ph phase_2

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution16 total trials

Phase 1Safety & dosage

1(6.3%)

Phase 2Efficacy & side effects

2(12.5%)

Phase 3Large-scale testing

2(12.5%)

Phase 4Post-market surveillance

5(31.3%)

N/ANon-phased studies

6(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(10)

Terminated(2)

Other(3)

Detailed Status

Completed10

unknown3

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (6.3%)

Phase 22 (12.5%)

Phase 32 (12.5%)

Phase 45 (31.3%)

N/A6 (37.5%)

Trials by Status

terminated213%

unknown319%

recruiting16%

completed1063%

Recent Activity

1 active trials

Showing 5 of 16

completednot_applicable

Clinical Trials (16)

Showing 16 of 16 trials

NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed

NCT02572791Phase 4

Staph Household Intervention for Eradication (SHINE)

Completed

NCT03489629Phase 2

STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)

Completed

NCT06541145Not Applicable

Bacterial Decolonization Within Dyads

Recruiting

NCT03173053Not Applicable

S. Aureus Decolonization in HPN Patients.

Terminated

NCT03673956Phase 1

Topical Antibiotics in Chronic Rhinosinusitis

Completed

NCT05251584Not Applicable

Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection

Unknown

NCT01269541Not Applicable

MESS-study MRSA Eradication Study Skåne

Completed

NCT02218307Phase 4

The Use of Antibiotic Sinonasal Rinse After Sinus Surgery

Completed

NCT01349192Phase 2

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Terminated

NCT01537783Phase 4

Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

Completed

NCT02963129Phase 3

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

Unknown

NCT02284555Phase 4

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Completed

NCT01949935Phase 3

Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting

Completed

NCT01152593Not Applicable

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Unknown

NCT00156377Phase 4

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

Completed

All 16 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 16